touchCARDIO touchCARDIO

EUROPEAN JOURNAL OF ARRHYTHMIA & ELECTROPHYSIOLOGY – VOLUME 9 SUPPLEMENT 1 – 2023

The official abstracts from the Heart Rhythm Congress (HRC) 2023

Young Investigators Competition

Oral Abstracts 1

Oral Abstracts 2

Oral Abstracts 3

Moderated Posters 1

Moderated Posters 2

Posters 1

Posters 2

Young Investigators Competition

Arrhythmia
Arrhythmia
3/Assessment of coronary perfusion, central and peripheral haemodynamics during simulated ventricular tachycardia and its potential application to implantable cardioverter defibrillators
AA Miyazawa (Presenting Author) - Imperial College London, London, UK; AD Arnold - Imperial College London, London, UK; H Seligman - Imperial College London, London, UK; R Bahl - Imperial College London, London, UK; N Ali - Imperial College London, London, UK; JS Mohal - Imperial College London, London, UK; A Naraen - Imperial College London, London, UK; M Liistro - Imperial college London, London, UK; S Bangi - Imperial College London, London, UK; L Doltu - Imperial College London, London, UK; D Keene - Imperial College London, London, UK; FS Ng - Imperial College London, London, UK; NWF Linton - Imperial College London, London, UK; NS Peters - Imperial College London, London, UK; BP Lim - Imperial College London, London, UK; MJ Shun-Shin - Imperial College London, London, UK; DP Francis - Imperial College London, London, UK; R Petraco - Imperial College London, London, UK; ZI Whinnett - Imperial College London, London, UK

Background: Extending implantable cardioverter defibrillator (ICD) detection windows improves outcomes by reducing unnecessary therapies; a 1% reduction in therapies results in ~1% reduction in mortality. However, waiting too long for episodes to self-terminate may prolong cardiac ischaemia, which could compromise the effectiveness of ICD treatments. We have previously shown that laser Doppler perfusion monitoring, combined […]

Arrhythmia
Arrhythmia
6/Neural network-derived electrocardiographic features predict mortality and future malignant arrhythmia and conduction disease
A Sau (Presenting Author) - Imperial College London, London, UK; AH Ribeiro - Uppsala University, Uppsala, Sweden; KA McGurk - Imperial College London, London, UK L Pastika - Imperial College London, London, UK; N Bajaj - Imperial College London, London, UK; M Ardissino - Imperial College London, London, UK; JY Chen - Imperial College London, London, UK; H Wu - Imperial College London, London, UK; X Shi - Imperial College London, London, UK; K Hnatkova - Imperial College London, London, UK; S Zheng - Imperial College London, London, UK; A Britton - University College London, London, UK; M Shipley - University College London, London, UK; I Andršová - University Hospital Brno and Masaryk University, Brno, Brno, Czech Republic; T Novotný - University Hospital Brno and Masaryk University, Brno, Brno, Czech Republic; E Sabino - University of São Paulo, São Paulo, Brazil; L Giatti - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; SM Barreto - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; JW Waks - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA; DB Kramer - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA; D Mandic - Imperial College London, London, UK; NS Peters - Imperial College London, London, UK; DP O’Regan - Imperial College London, London, UK; M Malik - Imperial College London, London, UK; JS Ware - Imperial College London, London, UK; ALP Ribeiro - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; FS Ng - Imperial College London, London, UK

Background: Subtle, prognostically-meaningful ECG features may not be apparent to physicians. In the course of supervised machine learning (ML) training, many thousands of ECG features are identified. These are not limited to conventional ECG parameters and morphology. These novel NN-derived ECG features may have clinical, phenotypic and genotypic associations and prognostic significance. Methods and results: […]

Oral Abstracts 1

Oral Abstracts 2

Atrial Fibrillation
Atrial Fibrillation
20/Response to cardiac resynchronization therapy in patients with atrial fibrillation versus sinus rhythm: A single UK centre study
C Sohrabi (Presenting Author) - Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK; N Papageorgiou - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; JSC Del Mundo - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; N Aziminia - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; K Mouyis - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; PD Lambiase - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; S Ahsan - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; P Moore - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; M Dhinoja - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; S Sporton - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; MJ Earley - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; RJ Schilling - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; C Hayward - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; R Providencia - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; R Hunter - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; AW Chow - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; A Muthumala - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK

Introduction: Cardiac resynchronization therapy (CRT) is widely used for the management of patients with heart failure (HF) and severe left ventricular (LV) systolic dysfunction with a wide QRS duration.1 However, there is currently limited evidence on its effectiveness in patients with atrial fibrillation (AF). The purpose of this study is to investigate response to CRT in […]

Oral Abstracts 3

Atrial Fibrillation
Atrial Fibrillation
39/Prospective and randomized study comparing PVAC gold catheter ablation versus clinical treatment in elderly patients with symptomatic atrial fibrillation
LCB Martins (Presenting Author) – Heart Institute Sao Paulo, Sao Paulo, Brazil; CF Pisani – Heart Institute Sao Paulo, Sao Paulo, Brazil; FK Dorfman – Heart Institute Sao Paulo, Sao Paulo, Brazil; FC Darrieux – Heart Institute Sao Paulo, Sao Paulo, Brazil; TC Wu – Heart Institute Sao Paulo, Sao Paulo, Brazil; DT Hachul – Heart Institute Sao Paulo, Sao Paulo, Brazil; CC Castro – Heart Institute Sao Paulo, Sao Paulo, Brazil; RR Prado – Heart Institute – Sao Paulo, Sao Paulo, Brazil; LVF Souza – Heart Institute Sao Paulo, Sao Paulo, Brazil; L Sacilloto – Heart Institute Sao Paulo, Sao Paulo, Brazil; GDA Pessente – Heart Institute Sao Paulo, Sao Paulo, Brazil; CJ Gruppi – Heart Institute Sao Paulo, Sao Paulo, Brazil; MO Chorkr – Heart Institute – Sao Paulo, Sao Paulo, Brazil; CH Nomura – Heart Institute – Sao Paulo, Sao Paulo, Brazil; KR Oliveira – Heart Institute – Sao Paulo, Sao Paulo, Brazil; CP Balbo – Heart Institute – Sao Paulo, Sao Paulo, Brazil; SL Melo – Heart Institute – Sao Paulo, Sao Paulo, Brazil; P Veronese – Heart Institute – Sao Paulo, Sao Paulo, Brazil; MI Scanavacca – Heart Institute – Sao Paulo, Sao Paulo, Brazil; AP Ferraz – Heart Institute Sao Paulo, Sao Paulo, Brazil

Aims: Compare catheter ablation (CA) using second-generation pulmonary vein ablation catheter (PVAC) gold technique with clinical treatment in elderly patients with symptomatic paroxysmal AF (PAF), without structural heart diseases. Methods: Prospective randomized study selected consecutive patients with paroxysmal AF ≥65 years in 2 groups: (1) the PVAC CA group and (2) the antiarrhythmic drug (AAD) therapy group. […]

Moderated Posters 1

Heart Failure
Heart Failure
42/Understanding the role of blood groups and Rhesus status in patients with heart failure with cardiac resynchronization therapy
N Papageorgiou – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; C Sohrabi (Presenting Author) – Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK; C Bakogiannis – 3rd Cardiology Department, Ippokrateion Hospital, Thessaloniki, Greece; A Tsarouchas – 3rd Cardiology Department, Ippokrateion Hospital, Thessaloniki, Greece; K Kukendrarajah – The Farr Institute of Health Informatics Research, University College London, London, UK; L Matiti – Broomfield Hospital, Mid and South Essex NHS Foundation Trust, Essex, UK; NT Srinivasan – Department of Cardiac Electrophysiology, Essex Cardiothoracic Centre, Basildon, UK; Syed Ahsan – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; S Sporton – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; RJ Schilling – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; R Hunter – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; A Muthumala – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; A Creta – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; AW Chow – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; R Providencia – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK

Introduction: The relationship between ABO blood group and Rhesus status with survival outcomes in patients with heart failure (HF) managed with CRT-P/D remains unclear. Understanding this association could provide valuable insights for developing innovative therapeutic approaches, guiding risk-stratification methods, and predicting clinical response to treatment. This retrospective single-centre observational study aimed to evaluate the role […]

Moderated Posters 2

Cardiovascular Disease, Interventional Cardiology
Cardiovascular Disease, Interventional Cardiology
50/Pre-procedural cardiac computer tomography and magnetic resonance for ventricular tachycardia catheter ablation: A UK single-centre experience
Authors: MA Sammut (Presenting Author) – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; R Oatham – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; M Mills – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; H Zafar – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; P Garg – Norfolk and Norwich University Hospital, Norwich, UK; J Lee – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; N Kelland – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; J Sahu – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; G Kirkwood – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; P Metherall – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; S Whiteman – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; G Smith – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; A Kyriacou – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Background: Catheter ablation is an effective therapy for ventricular tachycardia (VT) secondary to ischaemic heart disease (IHD), but its wider adoption is limited by procedure complexity and safety. Pre-procedural planning with cardiac computer tomography (CT) or magnetic resonance (MR) and their integration into electro-anatomical mapping (EAM) during ablation have sought to address some of the […]

Posters 1

Posters 2

Arrhythmia, Atrial Fibrillation
Arrhythmia, Atrial Fibrillation
88/’AssistMed’ project: A natural language processing tool for rapid atrial fibrillation cohort characterization from textual data in electronic health records
CM Maciejewski (Presenting Author) - 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland; KO Ozierański - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw; AB Barwiołek - none , Warsaw, Poland; MB Basza - Medical University of Silesia, Katowice, Poland; MC Ciurla - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; AB Bożym - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; MJK Krajsman - Department of Medical Informatics and Telemedicine of Medical University of Warsaw, Warsaw, Poland; MM Maciejewska - Medical University of Warsaw, Warsaw, Poland; PL Lodziński - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; GO Opolski - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; MG Grabowski - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; AC Cacko - Department of Medical Informatics and Telemedicine of Medical University of Warsaw, Warsaw, Poland; PB Balsam - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland

Background: Adoption of electronic health records (EHR) improved the availability of medical documentation for research purposes. However, significant proportion of data is in textual information that cannot be utilized for scientific purposes until it is analyzed through manual chart review. Utilization of only structured data from EHR is insufficient for comprehensive cohort characterization and of […]

  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72